Evogene | EVGN - Operating Expenses

Stock Price
313.60
Daily Change
1.30 0.42%
Monthly
-12.21%
Yearly
-41.27%
Q1 Forecast
309.23

Evogene reported $3.04M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
CVR Partners USD 110M 11.96M Sep/2025
Evogene USD 3.04M 920K Sep/2025
Hawkins USD 518.91M 11.94M Dec/2025
Innospec USD 404.7M 6.9M Jun/2025
Koppers USD 545.6M 97.5M Sep/2025
Kronos Worldwide USD 804.7M 307.7M Sep/2025
Materion USD 934.58M 539.42M Sep/2025
Minerals Technologies USD 453M 1000K Dec/2025
Rayonier Advanced Materials USD 338.21M 769K Sep/2025
Sensient Technologies USD 351.08M 2.1M Sep/2025
Stepan USD 567.45M 8.57M Sep/2025
Tronox USD 717M 7M Sep/2025
Valhi USD 1.05B 505.3M Sep/2025
WD-40 USD 131.16M 4.28M Sep/2025